MLOps is the set of practices used to move machine learning from experiments into reliable production services. It connects data preparation, training pipelines, experiment tracking, model registries, automated testing, deployment, monitoring, and retraining with software engineering and operational controls. Unlike ordinary application code, a model can degrade when incoming data or real-world behavior changes even if no code was modified. MLOps therefore tracks data quality, performance, drift, lineage, versions, and infrastructure alongside uptime and errors. Effective implementation also defines approval gates, rollback procedures, security, cost controls, and clear ownership among data scientists, engineers, platform teams, and domain experts.
The European Commission is proposing that Google share search data with rivals, including AI chatbots, as part of enforcement under the Digital Markets Act.
Anthropic is expanding its London presence with space for 800 staff, intensifying competition with OpenAI and other AI firms for talent in the U.K.
Strong forecasts from ASML and TSMC signal continued massive AI spending by tech giants, despite rising concerns over sustainability and supply constraints.
German banks and regulators are assessing risks tied to Anthropic’s Mythos model as concerns grow over AI-driven cyber threats to financial systems.
Nvidia unveils Ising, a new open-source AI model family designed to tackle quantum computing’s biggest bottlenecks: calibration and error correction.
OpenAI is scaling its Trusted Access for Cyber program and introducing GPT-5.4-Cyber to support vetted defenders as AI-driven security risks accelerate.
New AI cybersecurity systems like Anthropic’s Project Glasswing could increase demand for security professionals as threats and vulnerabilities scale faster.
Anthropic has introduced “Routines” in Claude Code, enabling autonomous AI workflows triggered by schedules, APIs, or GitHub events.
A new national poll shows 50% of Americans used AI in the past week, with ChatGPT leading adoption across work, learning, and creative tasks.
AWS has launched Amazon Bio Discovery, an AI-powered platform that helps scientists design, test, and refine drugs faster using integrated models and lab workflows.